RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

SM Gupta, J Mania-Pramanik - Journal of biomedical science, 2019 - Springer
Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of
mortality in developing countries. Persistent infection with high-risk human papillomavirus …

Oncogenic human papillomavirus: application of CRISPR/Cas9 therapeutic strategies for cervical cancer

S Zhen, X Li - Cellular Physiology and Biochemistry, 2018 - karger.com
Oncogenic human papillomaviruses (HPVs) cause different types of cancer especially
cervical cancer. HPV-associated carcinogenesis provides a classical model system for …

Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer

HS Jung, N Rajasekaran, W Ju, YK Shin - Journal of clinical medicine, 2015 - mdpi.com
Human papillomaviruses (HPVs) are small DNA viruses; some oncogenic ones can cause
different types of cancer, in particular cervical cancer. HPV-associated carcinogenesis …

Anti-human papillomavirus therapeutics: facts & future

AC Bharti, S Shukla, S Mahata, S Hedau… - Indian Journal of …, 2009 - journals.lww.com
Even after 25 years of establishing Human Papillomavirus (HPV) as the causative agent for
cervical cancer, effective treatment of HPV infection still unavailable. Comprehensive efforts …

Estrogen attenuates the growth of human papillomavirus-positive epithelial cells

ML Bristol, CD James, X Wang, CT Fontan, IM Morgan - Msphere, 2020 - Am Soc Microbiol
Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that are significant
risk factors in the development of cancer, and HPV accounts for approximately 5% of all …

[PDF][PDF] Therapeutic startegies for human papillomavirus infection and associated cancers

AC Bharti, T Singh, A Bhat, D Pande… - Front Biosci (Elite …, 2018 - article.imrpress.com
Human papillomavirus (HPV) infection is linked to development of cancer of cervix, vagina,
vulva, penis, ano-genital and non-genital oro-pharyngeal sites. HPV being a sexually …

The therapeutic potential of CRISPR/Cas9 systems in oncogene-addicted cancer types: virally driven cancers as a model system

L Jubair, NAJ McMillan - Molecular Therapy-Nucleic Acids, 2017 - cell.com
The field of gene editing is undergoing unprecedented growth. The first ex vivo human
clinical trial in China started in 2016, more than 1000 US patents have been filed, and there …

[HTML][HTML] The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus

U Ciesielska, K Nowińska… - … in Clinical and …, 2012 - advances.umw.edu.pl
Human papillomavirus (HPV) belongs to the diverse group of sexually transmitted viruses
that manifest affinity to the squamous epithelia of the skin and mucous membranes. Over …

Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus

QY Hu, E Fink, CK Grant, JH Elder - PloS one, 2014 - journals.plos.org
Heparan sulfate proteoglycans (HSPG) can act as binding receptors for certain laboratory-
adapted (TCA) strains of feline immunodeficiency virus (FIV) and human immunodeficiency …

La oncoproteína E7 del virus de papiloma humano y su papel en la transformación celular.

V Vallejo-Ruiz, N Velázquez-Márquez… - Revista Medica del …, 2015 - medigraphic.com
Human papillomavirus (HPV) genome codifies proteins with oncogenic activity, such as E7.
Due to its structural characteristics, the E7 protein may interact with a great variety of cellular …